Prior treatments received by line of therapy. Prior treatment received by t(11;14) status in 1L (A), 2L (B), and 3L+ (C) settings. Patients were counted once per type of prior therapy received. mAb, monoclonal antibody; PI, proteasome inhibitor; SCT, stem cell transplant.